Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
Capsules4.5 mg
Similar Products
RIVASTIGMINA ARENA 4.5 mg
Cholinesterase inhibitor indicated in the treatment of Alzheimer's type dementia
Active Substance (INN)
RIVASTIGMINUM
Packaging
3,4,11 bl x 10 caps
Adverse Reaction Reporting
To report an adverse reaction, please contact us using the email address below and provide all relevant information.
informatii.medicale@arenagroup.ro
Read the instructions for use carefully! Consult a doctor or pharmacist to find out about the risks and side effects.